Farallon Capital Management Portfolio

In its Q4 2024 13F filing, Farallon Capital Management disclosed 135 equity positions with a combined reported value of $19.71B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.9% of reported value. HoldingsHub classifies the profile as Large / High Turnover.

The largest disclosed positions as of Q4 2024 were SPY ($2.48B), EXEL ($780.54M), RSP ($771.01M). By sector, the heaviest allocations are Health Care 34.1%, Technology 15.6%. Versus the prior quarter, allocation shifted toward Health Care (+5.1pp), Technology (+1.6pp) and away from Consumer Discretionary (-2.1pp), Other (-5.6pp).

Versus the prior quarter, Farallon Capital Management opened 21 new positions, trimmed 23 and fully exited 103, a turnover rate of 77.8% of positions. The portfolio's overlap with the prior quarter was 67% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.